Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
other allergic reactions that have been reported include erythema, skin rash (unspecified), pruritus, general malaise, and respiratory difficulty due to bronchospasm
AHK-Cu, or Alanine-Histidine-Lysine-Copper, is a naturally occurring tripeptide complexed with copper that has been investigated for its role in activating copper-dependent enzymatic processes and modulating extracellular matrix proteins involved in tissue structure and repair
Frequently Asked Questions Common side effects include pain at the injection site, swelling, redness, and mild allergic reactions like itching or rash
US$ 21.18
US$ 20.79
US$ 28.60
US$ 21.73
US$ 23.71
US$ 27.32
US$ 28.17
